Literature DB >> 8626774

The sequence of human betaB1-crystallin cDNA allows mass spectrometric detection of betaB1 protein missing portions of its N-terminal extension.

L L David1, K J Lampi, A L Lund, J B Smith.   

Abstract

The sequence of human betaB1-crystallin cDNA encoded a protein of 251 amino acids in length. Mass spectrometric analysis of intact betaB1 from young human lens confirmed the deduced amino acid sequence. Lenses of human donors newborn to 27 years of age also contained partially degraded forms of betaB1 missing 15, 33, 34, 35, 36, 39, 40, and 41 amino acid residues from their N-terminal extensions. The similarity of the cleavage site between residues 15 and 16 in human betaB1 to the cleavage occurring in bovine betaB1 suggested that lenses of both species may contain a similar proteolytic activity. The remaining cleavage sites occurring in human betaB1 did not closely match those occurring in other species, possibly due to the widely divergent amino acid sequence of the N-terminal extension of betaB1 amoung species. Results from animal models suggest that cleavage of the N-terminal extension of betaB1-crystallin could enhance protein insolubilization and cataract in lens. However, the presence of partially degraded betaB1-crystallins in both water-soluble and water-insoluble fractions of lenses of young donors suggested that the rate that proteolyzed betaB1-crystallins become water-insoluble is relatively slow in humans.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8626774     DOI: 10.1074/jbc.271.8.4273

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Crystal structure of truncated human betaB1-crystallin.

Authors:  Rob L M Van Montfort; Orval A Bateman; Nicolette H Lubsen; Christine Slingsby
Journal:  Protein Sci       Date:  2003-11       Impact factor: 6.725

2.  Protein identification by spectral networks analysis.

Authors:  Nuno Bandeira; Dekel Tsur; Ari Frank; Pavel A Pevzner
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-02       Impact factor: 11.205

3.  UV filters in the lens of the thirteen lined ground squirrel (Spermophilus tridecemlineatus).

Authors:  P G Hains; M F Simpanya; F Giblin; R J W Truscott
Journal:  Exp Eye Res       Date:  2005-11-17       Impact factor: 3.467

Review 4.  Lens β-crystallins: the role of deamidation and related modifications in aging and cataract.

Authors:  Kirsten J Lampi; Phillip A Wilmarth; Matthew R Murray; Larry L David
Journal:  Prog Biophys Mol Biol       Date:  2014-03-06       Impact factor: 3.667

5.  Inhibition of unfolding and aggregation of lens protein human gamma D crystallin by sodium citrate.

Authors:  Daniel R Goulet; Kelly M Knee; Jonathan A King
Journal:  Exp Eye Res       Date:  2011-05-12       Impact factor: 3.467

6.  Modifications of human betaA1/betaA3-crystallins include S-methylation, glutathiolation, and truncation.

Authors:  Veniamin N Lapko; Ronald L Cerny; David L Smith; Jean B Smith
Journal:  Protein Sci       Date:  2004-12-02       Impact factor: 6.725

7.  The effect of N-terminal truncation on double-dimer assembly of goose delta-crystallin.

Authors:  Hwei-Jen Lee; Young-Hsang Lai; Su-Ying Wu; Yu-Hou Chen
Journal:  Biochem J       Date:  2005-12-15       Impact factor: 3.857

8.  Association properties of betaB1- and betaA3-crystallins: ability to form heterotetramers.

Authors:  May P Chan; Monika Dolinska; Yuri V Sergeev; Paul T Wingfield; J Fielding Hejtmancik
Journal:  Biochemistry       Date:  2008-09-30       Impact factor: 3.162

9.  Alterations in lenticular proteins during ageing and selenite-induced cataractogenesis in Wistar rats.

Authors:  Muniyan Sakthivel; Rajan Elanchezhian; Philip A Thomas; Pitchairaj Geraldine
Journal:  Mol Vis       Date:  2010-03-16       Impact factor: 2.367

10.  Degradation of C-terminal truncated alpha A-crystallins by the ubiquitin-proteasome pathway.

Authors:  Xinyu Zhang; Edward J Dudek; Bingfen Liu; Linlin Ding; Alexandre F Fernandes; Jack J Liang; Joseph Horwitz; Allen Taylor; Fu Shang
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-09       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.